Health Care/Hospital

Concord Medical Reports Financial Results for the First Half of 2023

BEIJING, Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extens...

2023-09-23 05:00 5199

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development

* Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug. Chime Biologics will provide development and manufacturing services to Panolos Bioscience for PB203, a next-generation immuno-oncology drug. WUHAN, China...

2023-09-22 20:15 1324

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

FOSTER CITY, Calif., Sept. 22, 2023 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has g...

2023-09-22 16:41 1177

FDA Grants Fast Track Designation to 9MW3011

SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that FDA has granted Fast Track Designation (FTD) to 9MW3011 (R&D code in the US: MWTX-003/DISC-3405) for the treatment of patients with polycythemia vera (P...

2023-09-22 08:00 1480

Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function

SAN DIEGO, Sept. 21, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals (Inmagene), a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced its partnership with Aditum Bio to create Celexor Bio (Celexor), a ne...

2023-09-21 21:00 3551

Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL

SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- Dizal announced today that the China National Medical Products Administration (NMPA) has granted priority review status to golidocitinib, Dizal's investigational JAK1-only inhibitor, for the treatment of relapsed or refractory peripheral T-cell lymphoma (r...

2023-09-21 20:26 1260

AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT

ADELAIDE, Australia and RALEIGH, N.C., Sept. 21, 2023 /PRNewswire/ -- Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, announces two key appointments in the US to support its continued global growth.

2023-09-21 19:30 1391

Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology

SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced the publication of two cases of the treatment of metastatic pancreat...

2023-09-21 16:00 1234

Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist

HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical-stage biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its HPG7233, an agonist of Thyroid H...

2023-09-20 22:00 1259

Taiwan's Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health

NISORO HEALTH introduces high-quality Pineapple Enzyme, a digestive elixir blendingTaiwan's pineapples and LJ88 probiotics. It enhances digestion, promotes gut health, and is suitable for all ages. TAIPEI, Sept. 20, 2023 /PRNewswire/ -- Taiwan is renowned for its exceptional products, and NISORO...

2023-09-20 21:00 1333

Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Sanyou Bio's consecutive wins reflect our clients' trust, and our proven track record, raising expectations for our future. This recognition from peers and industry experts motivate us to remain committed to our mission, and to consistently provide high-qu...

2023-09-20 20:00 1188

Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore

The new collaboration aims to advance accelerator science technologies for multidisciplinary real-world applications  SINGAPORE, Sept. 20, 2023 /PRNewswire/ -- The Centre for Ion Beam Applications  (CIBA), a multidisciplinary research centre at theNational U...

2023-09-20 19:31 1390

WuXi XDC Launches New Commercial Manufacturing Facilities

* New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product * Doubled capacity provides greater support to the rapidly growing global bioconjugate industry   WUXI, China, Sept. 20, 2023 /PRNewswire/ -- WuXi XDC, a ...

2023-09-20 18:51 1260

The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, has announced that the multinatio...

2023-09-20 15:52 1411

MedMatch360 Partnered Up with HokuApps to Disrupt Healthcare Recruitment Paradigm through Groundbreaking Technology, Streamlining Processes and Elevating Candidate-Organization Connection

SYKESVILLE, Md., Sept. 19, 2023 /PRNewswire/ -- Together they implemented a powerful all-in-one mobility solution revolutionizing the recruitment experience by eliminating frustrations and enhancing efficiency for recruiters and healthcare providers, enabling swift identification of ideal matches...

2023-09-19 23:08 1154

Neusoft Holds the Top Market Share of Medical Imaging Information System in China

SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022", in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continu...

2023-09-19 17:00 1441

Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment

TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focusing on breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics, announced the completion of subject recruitment in the CBL-0201EFP Phase 2-stage...

2023-09-19 11:16 1036

ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand...

2023-09-19 09:16 1355

VUNO's First AI-based Prospective Study Results Published in Critical Care

SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company announced that its AI-based cardiac arrest risk management system, VUNO Med®-DeepCARS™, has proven its clinical validity for the first time through a prospective study utilizing Real World Data(RWD). <...

2023-09-18 21:00 1296

Lexasure Financial Group Founder & CEO Ian Lim to Receive BrandLaureate Awards for Digital Insurance Solutions and Visionary Entrepreneur of the Year

GEORGETOWN, Cayman Islands, Sept. 18, 2023 /PRNewswire/ -- Lexasure Financial Group Limited ("Lexasure" or the "Company"), a provider of reinsurance, insurance, and insurtech solutions in South and Southeast Asia, today announced that the Company has been selected as th...

2023-09-18 21:00 1062
1 ... 30313233343536 ... 252

Week's Top Stories